People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| QRails, Inc. | — | Other Technology | Series A | $35.2M | $53.9M | 2018 |
| Neuraptive Therapeutics, Inc. | — | Biotechnology | Series B | $29.8M | $295.3M | 2018 |
| Terressentia Corp | — | Other | Series B | $24.0M | $398.8M | 2017 |
| EvinceMed Corp. | — | Other | Seed | $3.7M | $68.8M | 2018 |
David Jackson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Jackson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rajan Gupta | 1 | 7 |
| Joseph Whitters | 1 | 4 |
| Gino DiSciullo | 1 | 4 |
| STEVEN MILLS | 1 | 3 |
| William Weisman | 1 | 2 |
| Laurence Molke | 1 | 2 |
| Gerard Griffin | 1 | 2 |
| Melanie Barker | 1 | 2 |
| Brian Brinkley | 1 | 2 |
| Ivan Gergel | 1 | 2 |
| Edward Bailey | 1 | 2 |
| Robert S Radie | 1 | 2 |
| Ivan S Gergel | 1 | 1 |
| David S Jackson | 1 | 1 |
| Evan S Tzanis | 1 | 1 |
| Greg Parekh | 1 | 1 |
| Randy Hubbell | 1 | 1 |
| David M Jackson | 1 | 1 |
| Fredrick Waid | 1 | 1 |
| John Akridge | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.